SEBI Chairman Tuhin Kanta Pandey has announced that the regulator is developing guidelines for the responsible use of artificial intelligence and machine learning in financial markets. Additionally, SEBI has formed a working group to review the Innovators Growth Platform to make it more accessible for deep-tech and biotech startups.

Amid a rising number of cyberattacks targeting financial institutions and cryptocurrency platforms globally, the Securities and Exchange Board of India (SEBI) has stated that its regulatory systems are continuously evolving to handle emerging disruptions. SEBI Chairman Tuhin Kanta Pandey noted that vulnerability testing, patch testing, and patching activities are ongoing to safeguard market infrastructure.

Speaking on the sidelines of the 45th India International Trade Fair (IITF) 2026 in New Delhi, Pandey announced that SEBI will soon issue detailed guidelines governing the responsible use of artificial intelligence (AI) and machine learning (ML) in financial markets. The proposed framework focuses on establishing clear guardrails, including mandatory disclosures, accountability for regulated entities, and a human-in-the-loop approach to ensure critical decisions remain under human oversight. This follows a consultation paper floated by SEBI in June 2025 outlining guiding principles to balance innovation with investor protection and market integrity.

Addressing modern technological risks, Pandey highlighted that SEBI introduced a structured incident response mechanism in May, aligned with the Financial Stability Board’s FIRE reporting template. Regarding quantum computing, the regulator is currently taking an inventory of cryptographic systems to identify and address vulnerabilities ahead of anticipated risks expected to emerge between 2032 and 2035. SEBI has also developed internal supervisory tools, such as the 'Sudarshan' tool, which has been showcased at international forums.

In a significant development for early-stage companies and entrepreneurs, the SEBI chief stated that the regulator has formed a working group to examine ways to make the Innovators Growth Platform (IGP) more attractive. Acknowledging that the existing platform has not achieved the desired traction, the review specifically targets deep-tech and biotech startups that typically require long gestation periods prior to achieving profitability.

The objective of the ongoing review is to enable such high-risk, capital-intensive businesses to access public markets at an earlier stage while providing clear disclosures to investors regarding the associated risks and long-term growth potential.

"SEBI's initiative to review the Innovators Growth Platform is a necessary step for the Indian startup ecosystem. Deep-tech and biotech startups face long gestation periods and often struggle with traditional listing requirements. Making public markets accessible earlier—while maintaining clear risk disclosures and human oversight on AI integration—will help build a more transparent, resilient, and growth-oriented environment for both founders and public investors." — Dr. Shishir Gupta, Founder & CEO, StartupLanes

Recent StartupLanes Articles

Browse through our 30 latest publications on venture capital, startups, and angel investing.